Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and...
NASDAQ:OCUL Ocular Therapeutix Inc Long term Target PT 29 and higher Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology in the United States. The company markets ReSure Sealant, an...
OCUL is shaping up for a good risk reward set up. $3.60 before resistance and well within major downtrend line. Starter position below $3. Will add if it falls closer to $2.50, where it has lots of support. Profit opportunity is 10 - 20%
looking for the test of the gap down that happen in OCT 21
OCUL created a pro gap and if price comes to retest , planning to take a long swing poistion to fill the sep 22 gap .
Cup and Handle formation Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology. The company markets ReSure Sealant, an ophthalmic device designed to prevent wound leaks in corneal incisions...
This is a great example of a chart that makes me realize there is much more to learn. I know there is a way to classify almost every market, but for the life of me I don't know this one. That makes me all the more motivated to monitor it, however.
Entry signal 21.16, stop 17.43. First target 29.83
The stock is showing a good wave structure It has a bit of spiky pullback during its wave 4 The candles have broken the highs and failed a few times Apart from the above, it's looking really good for another push-up I've lost 0.5R on it once. If this second and final attempt goes well then I will recover the previous investment and plus 1R on top. So here we...
NASDAQ:OCUL is about to break out. Long the break out at 20, the anticipated price action is shown on the chart, stop at 17$. Hit the like button and follow if you find this useful :) This is only my own view and not financial advice, do your own analysis before buying or selling Happy Trading!
Wait for the 4hr candle to close above $19 for confirmation, has been rejected by this downward channel multiple times.
Here we have another stock with a lovely wave 3 up a nice not too complex wave 4 down price has squeezed into a tight box allowing us to take a tight 3 dollar stop Entry Price $21 Stop $18 (or maybe even 18.50) Target 1: $23.50 Target 2: $26 Fingers Crossed!!! Company Profile Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the...
Entry price : 19.54 Fundamentals : - Sector: Medical - EPS % Chg (Last Qtr): 48% - EPS % Chg (Previous Qtr): -12% - 3 Year EPS Growth Rate: 0% - EPS Est % Chg (Current Yr): 0% - Sales % Chg (Last Qtr): 608% - Sales % Chg (Previous Qtr): 142% - 3-Year Sales Growth Rate: 75% - Annual Pre -Tax Margin: -2043.3%
$OCUL someone bought a bunch of Jan 2021 expiry 23C's early this afternoon. This name isn't a big option trader with average daily option volume barely over 400 contracts. Volume today on the 23C strike is currently 1058 against only 16 contract OI. They paid around 1.60 to 1.80.
Contextual immersion trading strategy idea. Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology. The share price rose after the company announced topline phase 1 clinical trial results of...